A trader working after the Nasdaq opening ceremony on April 18, 2019 in New York City.
I have Betancur | Getty Images
Check out the companies that make news after the bell on Monday:
Zoom Video: The shares of the video communications company appeared 8.5% behind the best fiscal results for the fourth quarter. Zoom earned $ 1.22 per share with revenue of $ 882 million. Analysts surveyed by Refinitiv expected a profit of 79 cents per share on revenue of $ 812 million. This revenue figure represents an increase of 369% year-on-year. Zoom also expects revenue to increase 175% in the first fiscal quarter and 42% throughout the fiscal year.
Roku: Roku shares jumped 2.8% on news that the company will acquire Nielsen’s video advertising business. “The combination of Nielsen’s AVA technology with Roku’s innovative advertising technology and scale will allow us to offer the benefits of streaming TV advertising over traditional television,” said Louqman Parampath, Roku’s vice president of product management.
Novavax: Vaccine developer shares fell 4.2% after the company reported weaker-than-expected fourth-quarter results. Novavax lost $ 2.70 per share in revenue of $ 279.7 million. Analysts polled by Refinitv expected a $ 1.49 per share loss on revenue of $ 304.9 million. CEO Stanley Erck told CNBC that the company is awaiting government approval for its Covid-19 vaccine as early as May.
Inovio Pharmaceuticals: Inovio shares fell more than 6% after the company released its latest quarterly figures. The company lost 14 cents per share, while analysts surveyed by FactSet expected a loss of 22 cents per share. In addition, Inovio published the results of the phase 3 test of a drug aimed at treating HPV.